Analysts Offer Predictions for Inovalis Real Estate Investment Trust’s FY2024 Earnings (TSE:INO)

Inovalis Real Estate Investment Trust (TSE:INO) – Equities research analysts at Desjardins dropped their FY2024 earnings per share (EPS) estimates for shares of Inovalis Real Estate Investment Trust in a research report issued on Wednesday, August 14th. Desjardins analyst A. Leon now expects that the company will earn $0.06 per share for the year, down from their prior estimate of $0.07. Desjardins also issued estimates for Inovalis Real Estate Investment Trust’s FY2025 earnings at $0.05 EPS.

Inovalis Real Estate Investment Trust Price Performance

About Inovalis Real Estate Investment Trust

Inovio Pharmaceuticals, Inc, a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.